FGFR1 and gastric cancer: Collectively, these results suggested that Y14, as an effective inhibitor of FGFR1, synergistically enhanced the anti-cancer effect of 5-FU by inhibiting FGFR1 phosphorylation in two gastric cancer cell lines.